However, if it improves your adherence and tolerability, the theoretical pharmacokinetic disadvantage may not matter practically
You're injecting inactive compound
If anemia and symptoms are severe, early labs (e.g
Dyspepsia, characterized by upper abdominal discomfort, early satiety, or postprandial fullness, may affect a similar proportion of patients and can contribute to reduced caloric intake and weight loss, though it may also impact quality of life if severe or persistent
Track fasting plasma free fatty acids (FFA) and beta-hydroxybutyrate (BHB) to confirm lipolytic activityAOD-9604 should elevate FFA by 3050% within 2 hours post-injection
Common disposal options often include taking the full container to a designated drop-off location, such as a local pharmacy, a doctors office, a hospital, or a hazardous waste collection site